SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

CVB CurveBeam AI Limited

Healthcare · Medical Devices · website
$0.02
52wk 0.02 – 0.13
Overall
39.0
Value
96.2
Growth
0.0
Health
69.6
Quality
0.0
Momentum
13.1
Dividend
—
Price
About CurveBeam AI Limited

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

Price analytics

Returns

1 day -4.5%
1 week -12.5%
1 month 5.0%
3 months 16.7%
6 months -64.4%
1 year -77.9%
3 years -94.5%

Risk

Volatility (1y ann.) 87.2%
Beta vs ASX 200 1.03
Sharpe (1y) -1.34
VaR 95% (1-day) -9.1%
Max drawdown (1y) -82.4%
Off 1-year high -76.9%

Technicals

RSI(14) 52
vs 50DMA 1.6%
vs 200DMA -55.7%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 96.2
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
86
Growth 0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 69.6
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
62
Debt / Equity
76
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 13.1
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
58
Position in 52-week range
4

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$17.95M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.04
Dividend yield
—
Payout ratio
0.0%
Beta
2.03
EV / EBITDA
-1.82
Price / Book
0.36
ROE
-59.9%
Operating margin
-219.4%
Net margin
-217.3%
Total cash
$1.64M
Total debt
$17.65M
Current ratio
1.85
Debt / Equity
0.64
Free cash flow
$-4.61M
Avg volume
1.16M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue—
  • Gross profit—
  • Operating income—
  • Net income—
  • Diluted EPS-0.04
  • Free cash flow—
  • Net debt—
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4